51342 Four-weekly dosing intervals with subcutaneous spesolimab appear to be required for optimal prevention of generalized pustular psoriasis flares: Data from the Effisayil 2 and Effisayil ON trials

• DOI: 10.1016/j.jaad.2024.07.192
• Publication Date: 2024-09-01T16:51:57Z
• Authors: Diamant Thaçi; Akimichi Morita; Bruce Strober; Tiago Torres; Andreas Pinter; Angelo V. Marzano; James G. Krueger; Ming Tang; Patrick Hofmann; Christian Thoma; Mark G. Lebwohl
• Keywords: Generalized pustular psoriasis